APO Research
Talk to an analyst

APO RESEARCH · REPORT

Network Point-of-Care Glucose Testing Device

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Network Point-of-Care Glucose Testing Device Market Outlook and Growth Opportunities 2026

4 July 2026208 pages

Choose your research edition.

Industry ResearchNetwork Point-of-Care Glucose Testing Device Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Network Point-of-Care Glucose Testing Device Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Network Point-of-Care Glucose Testing Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Network Point-of-Care Glucose Testing Device Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Network Point-of-Care Glucose Testing Device Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Network Point-of-Care Glucose Testing Device market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Network Point-of-Care Glucose Testing Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Network Point-of-Care Glucose Testing Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Network Point-of-Care Glucose Testing Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Network Point-of-Care Glucose Testing Device market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Network Point-of-Care Glucose Testing Device market include Johnson & Johnson, Trividia Health, Inc., Terumo, Roche Holding AG, Prodigy Diabetes Care, Panasonic Healthcare Holdings, Omron, Nova Biomedical and Nipro, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Network Point-of-Care Glucose Testing Device market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Network Point-of-Care Glucose Testing Device and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Network Point-of-Care Glucose Testing Device sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Network Point-of-Care Glucose Testing Device market size, projected growth trends, production technologies, key applications, and end-use industries.

Network Point-of-Care Glucose Testing Device Segment by Company

Johnson & Johnson

Trividia Health, Inc.

Terumo

Roche Holding AG

Prodigy Diabetes Care

Panasonic Healthcare Holdings

Omron

Nova Biomedical

Nipro

LifeScan, Inc.

EKF Diagnostics

Danaher Corporation

B. Braun

Ascensia Diabetes Care Holdings AG

AgaMatrix

ACON Laboratories, Inc.

77 Elektronika

Network Point-of-Care Glucose Testing Device Segment by Type

0.5uL/0.6uL

1.5uL

1uL

Others

Network Point-of-Care Glucose Testing Device Segment by Application

Clinic

Hospital

Household

Network Point-of-Care Glucose Testing Device Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Network Point-of-Care Glucose Testing Device status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Network Point-of-Care Glucose Testing Device market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Network Point-of-Care Glucose Testing Device significant trends, drivers, influence factors in global and regions.

6. To analyze Network Point-of-Care Glucose Testing Device competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Network Point-of-Care Glucose Testing Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Network Point-of-Care Glucose Testing Device and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Network Point-of-Care Glucose Testing Device.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Network Point-of-Care Glucose Testing Device market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Network Point-of-Care Glucose Testing Device industry.

Chapter 3: Detailed analysis of Network Point-of-Care Glucose Testing Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Network Point-of-Care Glucose Testing Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Network Point-of-Care Glucose Testing Device in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Network Point-of-Care Glucose Testing Device Industry Trends Table 2. Network Point-of-Care Glucose Testing Device Industry Drivers Table 3. Network Point-of-Care Glucose Testing Device Industry Opportunities and Challenges Table 4. Network Point-of-Care Glucose Testing Device Industry Restraints Table 5. Global Network Point-of-Care Glucose Testing Device Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Network Point-of-Care Glucose Testing Device Revenue Share by Company (2021-2026) Table 7. Global Network Point-of-Care Glucose Testing Device Sales Volume by Company (k units) & (2021-2026) Table 8. Global Network Point-of-Care Glucose Testing Device Sales Volume Share by Company (2021-2026) Table 9. Global Network Point-of-Care Glucose Testing Device Average Price (USD/unit) of Company (2021-2026) Table 10. Global Network Point-of-Care Glucose Testing Device Company Ranking, (2024-2026) & (USD Million) Table 11. Global Network Point-of-Care Glucose Testing Device Key Company Manufacturing Base & Headquarters Table 12. Global Network Point-of-Care Glucose Testing Device Company, Product Type & Application Table 13. Global Network Point-of-Care Glucose Testing Device Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Network Point-of-Care Glucose Testing Device by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 0.5uL/0.6uL Table 18. Significant Companies of 1.5uL Table 19. Significant Companies of 1uL Table 20. Significant Companies of Others Table 21. Global Network Point-of-Care Glucose Testing Device Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Network Point-of-Care Glucose Testing Device Sales Volume by Type (2021-2026) & (k units) Table 23. Global Network Point-of-Care Glucose Testing Device Sales Volume by Type (2027-2032) & (k units) Table 24. Global Network Point-of-Care Glucose Testing Device Sales Volume Share by Type (2021-2026) Table 25. Global Network Point-of-Care Glucose Testing Device Sales Volume Share by Type (2027-2032) Table 26. Global Network Point-of-Care Glucose Testing Device Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Network Point-of-Care Glucose Testing Device Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Network Point-of-Care Glucose Testing Device Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Network Point-of-Care Glucose Testing Device Sales Value Share by Type (2021-2026) Table 30. Global Network Point-of-Care Glucose Testing Device Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Clinic Table 32. Significant Companies of Hospital Table 33. Significant Companies of Household Table 34. Global Network Point-of-Care Glucose Testing Device Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Network Point-of-Care Glucose Testing Device Sales Volume by Application (2021-2026) & (k units) Table 36. Global Network Point-of-Care Glucose Testing Device Sales Volume by Application (2027-2032) & (k units) Table 37. Global Network Point-of-Care Glucose Testing Device Sales Volume Share by Application (2021-2026) Table 38. Global Network Point-of-Care Glucose Testing Device Sales Volume Share by Application (2027-2032) Table 39. Global Network Point-of-Care Glucose Testing Device Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Network Point-of-Care Glucose Testing Device Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Network Point-of-Care Glucose Testing Device Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Network Point-of-Care Glucose Testing Device Sales Value Share by Application (2021-2026) Table 43. Global Network Point-of-Care Glucose Testing Device Sales Value Share by Application (2027-2032) Table 44. Global Network Point-of-Care Glucose Testing Device Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Network Point-of-Care Glucose Testing Device Sales by Region (2021-2026) & (k units) Table 46. Global Network Point-of-Care Glucose Testing Device Sales Market Share by Region (2021-2026) Table 47. Global Network Point-of-Care Glucose Testing Device Sales by Region (2027-2032) & (k units) Table 48. Global Network Point-of-Care Glucose Testing Device Sales Market Share by Region (2027-2032) Table 49. Global Network Point-of-Care Glucose Testing Device Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Network Point-of-Care Glucose Testing Device Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Network Point-of-Care Glucose Testing Device Sales Value Share by Region (2021-2026) Table 52. Global Network Point-of-Care Glucose Testing Device Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Network Point-of-Care Glucose Testing Device Sales Value Share by Region (2027-2032) Table 54. Global Network Point-of-Care Glucose Testing Device Market Average Price (USD/unit) by Region (2021-2026) Table 55. Global Network Point-of-Care Glucose Testing Device Market Average Price (USD/unit) by Region (2027-2032) Table 56. Global Network Point-of-Care Glucose Testing Device Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 57. Global Network Point-of-Care Glucose Testing Device Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Network Point-of-Care Glucose Testing Device Sales by Country (2021-2026) & (k units) Table 59. Global Network Point-of-Care Glucose Testing Device Sales Market Share by Country (2021-2026) Table 60. Global Network Point-of-Care Glucose Testing Device Sales by Country (2027-2032) & (k units) Table 61. Global Network Point-of-Care Glucose Testing Device Sales Market Share by Country (2027-2032) Table 62. Global Network Point-of-Care Glucose Testing Device Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Network Point-of-Care Glucose Testing Device Sales Value Market Share by Country (2021-2026) Table 64. Global Network Point-of-Care Glucose Testing Device Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Network Point-of-Care Glucose Testing Device Sales Value Market Share by Country (2027-2032) Table 66. Johnson & Johnson Company Information Table 67. Johnson & Johnson Business Overview Table 68. Johnson & Johnson Network Point-of-Care Glucose Testing Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 69. Johnson & Johnson Network Point-of-Care Glucose Testing Device Product Portfolio Table 70. Johnson & Johnson Recent Development Table 71. Trividia Health, Inc. Company Information Table 72. Trividia Health, Inc. Business Overview Table 73. Trividia Health, Inc. Network Point-of-Care Glucose Testing Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 74. Trividia Health, Inc. Network Point-of-Care Glucose Testing Device Product Portfolio Table 75. Trividia Health, Inc. Recent Development Table 76. Terumo Company Information Table 77. Terumo Business Overview Table 78. Terumo Network Point-of-Care Glucose Testing Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 79. Terumo Network Point-of-Care Glucose Testing Device Product Portfolio Table 80. Terumo Recent Development Table 81. Roche Holding AG Company Information Table 82. Roche Holding AG Business Overview Table 83. Roche Holding AG Network Point-of-Care Glucose Testing Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 84. Roche Holding AG Network Point-of-Care Glucose Testing Device Product Portfolio Table 85. Roche Holding AG Recent Development Table 86. Prodigy Diabetes Care Company Information Table 87. Prodigy Diabetes Care Business Overview Table 88. Prodigy Diabetes Care Network Point-of-Care Glucose Testing Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. Prodigy Diabetes Care Network Point-of-Care Glucose Testing Device Product Portfolio Table 90. Prodigy Diabetes Care Recent Development Table 91. Panasonic Healthcare Holdings Company Information Table 92. Panasonic Healthcare Holdings Business Overview Table 93. Panasonic Healthcare Holdings Network Point-of-Care Glucose Testing Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Panasonic Healthcare Holdings Network Point-of-Care Glucose Testing Device Product Portfolio Table 95. Panasonic Healthcare Holdings Recent Development Table 96. Omron Company Information Table 97. Omron Business Overview Table 98. Omron Network Point-of-Care Glucose Testing Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Omron Network Point-of-Care Glucose Testing Device Product Portfolio Table 100. Omron Recent Development Table 101. Nova Biomedical Company Information Table 102. Nova Biomedical Business Overview Table 103. Nova Biomedical Network Point-of-Care Glucose Testing Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Nova Biomedical Network Point-of-Care Glucose Testing Device Product Portfolio Table 105. Nova Biomedical Recent Development Table 106. Nipro Company Information Table 107. Nipro Business Overview Table 108. Nipro Network Point-of-Care Glucose Testing Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Nipro Network Point-of-Care Glucose Testing Device Product Portfolio Table 110. Nipro Recent Development Table 111. LifeScan, Inc. Company Information Table 112. LifeScan, Inc. Business Overview Table 113. LifeScan, Inc. Network Point-of-Care Glucose Testing Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. LifeScan, Inc. Network Point-of-Care Glucose Testing Device Product Portfolio Table 115. LifeScan, Inc. Recent Development Table 116. EKF Diagnostics Company Information Table 117. EKF Diagnostics Business Overview Table 118. EKF Diagnostics Network Point-of-Care Glucose Testing Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. EKF Diagnostics Network Point-of-Care Glucose Testing Device Product Portfolio Table 120. EKF Diagnostics Recent Development Table 121. Danaher Corporation Company Information Table 122. Danaher Corporation Business Overview Table 123. Danaher Corporation Network Point-of-Care Glucose Testing Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Danaher Corporation Network Point-of-Care Glucose Testing Device Product Portfolio Table 125. Danaher Corporation Recent Development Table 126. B. Braun Company Information Table 127. B. Braun Business Overview Table 128. B. Braun Network Point-of-Care Glucose Testing Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. B. Braun Network Point-of-Care Glucose Testing Device Product Portfolio Table 130. B. Braun Recent Development Table 131. Ascensia Diabetes Care Holdings AG Company Information Table 132. Ascensia Diabetes Care Holdings AG Business Overview Table 133. Ascensia Diabetes Care Holdings AG Network Point-of-Care Glucose Testing Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. Ascensia Diabetes Care Holdings AG Network Point-of-Care Glucose Testing Device Product Portfolio Table 135. Ascensia Diabetes Care Holdings AG Recent Development Table 136. AgaMatrix Company Information Table 137. AgaMatrix Business Overview Table 138. AgaMatrix Network Point-of-Care Glucose Testing Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. AgaMatrix Network Point-of-Care Glucose Testing Device Product Portfolio Table 140. AgaMatrix Recent Development Table 141. ACON Laboratories, Inc. Company Information Table 142. ACON Laboratories, Inc. Business Overview Table 143. ACON Laboratories, Inc. Network Point-of-Care Glucose Testing Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 144. ACON Laboratories, Inc. Network Point-of-Care Glucose Testing Device Product Portfolio Table 145. ACON Laboratories, Inc. Recent Development Table 146. 77 Elektronika Company Information Table 147. 77 Elektronika Business Overview Table 148. 77 Elektronika Network Point-of-Care Glucose Testing Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 149. 77 Elektronika Network Point-of-Care Glucose Testing Device Product Portfolio Table 150. 77 Elektronika Recent Development Table 151. Key Raw Materials Table 152. Raw Materials Key Suppliers Table 153. Network Point-of-Care Glucose Testing Device Distributors List Table 154. Network Point-of-Care Glucose Testing Device Customers List Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Network Point-of-Care Glucose Testing Device Product Image Figure 2. Global Network Point-of-Care Glucose Testing Device Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Network Point-of-Care Glucose Testing Device Sales Value (2021-2032) & (US$ Million) Figure 4. Global Network Point-of-Care Glucose Testing Device Sales (2021-2032) & (k units) Figure 5. Global Network Point-of-Care Glucose Testing Device Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Network Point-of-Care Glucose Testing Device Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 0.5uL/0.6uL Image Figure 10. 1.5uL Image Figure 11. 1uL Image Figure 12. Others Image Figure 13. Global Network Point-of-Care Glucose Testing Device Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Network Point-of-Care Glucose Testing Device Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Network Point-of-Care Glucose Testing Device Sales Volume Share by Type (2021-2032) Figure 16. Global Network Point-of-Care Glucose Testing Device Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Network Point-of-Care Glucose Testing Device Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Network Point-of-Care Glucose Testing Device Sales Value Share by Type (2021-2032) Figure 19. Clinic Image Figure 20. Hospital Image Figure 21. Household Image Figure 22. Global Network Point-of-Care Glucose Testing Device Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Network Point-of-Care Glucose Testing Device Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Network Point-of-Care Glucose Testing Device Sales Volume Share by Application (2021-2032) Figure 25. Global Network Point-of-Care Glucose Testing Device Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Network Point-of-Care Glucose Testing Device Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Network Point-of-Care Glucose Testing Device Sales Value Share by Application (2021-2032) Figure 28. Global Network Point-of-Care Glucose Testing Device Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 29. Global Network Point-of-Care Glucose Testing Device Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Network Point-of-Care Glucose Testing Device Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Network Point-of-Care Glucose Testing Device Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Network Point-of-Care Glucose Testing Device Sales Value (2021-2032) & (US$ Million) Figure 33. North America Network Point-of-Care Glucose Testing Device Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Network Point-of-Care Glucose Testing Device Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Network Point-of-Care Glucose Testing Device Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Network Point-of-Care Glucose Testing Device Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Network Point-of-Care Glucose Testing Device Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Network Point-of-Care Glucose Testing Device Sales Value (2021-2032) & (US$ Million) Figure 39. South America Network Point-of-Care Glucose Testing Device Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Network Point-of-Care Glucose Testing Device Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Network Point-of-Care Glucose Testing Device Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Network Point-of-Care Glucose Testing Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Network Point-of-Care Glucose Testing Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Network Point-of-Care Glucose Testing Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Network Point-of-Care Glucose Testing Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Network Point-of-Care Glucose Testing Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Network Point-of-Care Glucose Testing Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Network Point-of-Care Glucose Testing Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Network Point-of-Care Glucose Testing Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Network Point-of-Care Glucose Testing Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Network Point-of-Care Glucose Testing Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Network Point-of-Care Glucose Testing Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Network Point-of-Care Glucose Testing Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Network Point-of-Care Glucose Testing Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Network Point-of-Care Glucose Testing Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Network Point-of-Care Glucose Testing Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Network Point-of-Care Glucose Testing Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Network Point-of-Care Glucose Testing Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Network Point-of-Care Glucose Testing Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Network Point-of-Care Glucose Testing Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Network Point-of-Care Glucose Testing Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Network Point-of-Care Glucose Testing Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Network Point-of-Care Glucose Testing Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Network Point-of-Care Glucose Testing Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Network Point-of-Care Glucose Testing Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Network Point-of-Care Glucose Testing Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Network Point-of-Care Glucose Testing Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Network Point-of-Care Glucose Testing Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Network Point-of-Care Glucose Testing Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Network Point-of-Care Glucose Testing Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Network Point-of-Care Glucose Testing Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Network Point-of-Care Glucose Testing Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Network Point-of-Care Glucose Testing Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Network Point-of-Care Glucose Testing Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Network Point-of-Care Glucose Testing Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Network Point-of-Care Glucose Testing Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Network Point-of-Care Glucose Testing Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Network Point-of-Care Glucose Testing Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Network Point-of-Care Glucose Testing Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Network Point-of-Care Glucose Testing Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Network Point-of-Care Glucose Testing Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Network Point-of-Care Glucose Testing Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Network Point-of-Care Glucose Testing Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Network Point-of-Care Glucose Testing Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Network Point-of-Care Glucose Testing Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Network Point-of-Care Glucose Testing Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Network Point-of-Care Glucose Testing Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Network Point-of-Care Glucose Testing Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Network Point-of-Care Glucose Testing Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Network Point-of-Care Glucose Testing Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Network Point-of-Care Glucose Testing Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Network Point-of-Care Glucose Testing Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Network Point-of-Care Glucose Testing Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Network Point-of-Care Glucose Testing Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Network Point-of-Care Glucose Testing Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Network Point-of-Care Glucose Testing Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Network Point-of-Care Glucose Testing Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Network Point-of-Care Glucose Testing Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Network Point-of-Care Glucose Testing Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Network Point-of-Care Glucose Testing Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Network Point-of-Care Glucose Testing Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Network Point-of-Care Glucose Testing Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Network Point-of-Care Glucose Testing Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Network Point-of-Care Glucose Testing Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Network Point-of-Care Glucose Testing Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Network Point-of-Care Glucose Testing Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Network Point-of-Care Glucose Testing Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Network Point-of-Care Glucose Testing Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Network Point-of-Care Glucose Testing Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Network Point-of-Care Glucose Testing Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Network Point-of-Care Glucose Testing Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Network Point-of-Care Glucose Testing Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Network Point-of-Care Glucose Testing Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Network Point-of-Care Glucose Testing Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Network Point-of-Care Glucose Testing Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Network Point-of-Care Glucose Testing Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Network Point-of-Care Glucose Testing Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Network Point-of-Care Glucose Testing Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Network Point-of-Care Glucose Testing Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Network Point-of-Care Glucose Testing Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Network Point-of-Care Glucose Testing Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Network Point-of-Care Glucose Testing Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Network Point-of-Care Glucose Testing Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Network Point-of-Care Glucose Testing Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Network Point-of-Care Glucose Testing Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Network Point-of-Care Glucose Testing Device Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Network Point-of-Care Glucose Testing Device Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • 0.5uL/0.6uL
  • 1.5uL
  • 1uL
  • Others
Applications
  • Clinic
  • Hospital
  • Household
Companies covered
  • Johnson & Johnson
  • Trividia Health, Inc.
  • Terumo
  • Roche Holding AG
  • Prodigy Diabetes Care
  • Panasonic Healthcare Holdings
  • Omron
  • Nova Biomedical
  • Nipro
  • LifeScan, Inc.
  • EKF Diagnostics
  • Danaher Corporation
  • B. Braun
  • Ascensia Diabetes Care Holdings AG
  • AgaMatrix
  • ACON Laboratories, Inc.
  • 77 Elektronika

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Network Point-of-Care Glucose Testing Device Sales Value (2021-2032)
  4. 1.2.2 Global Network Point-of-Care Glucose Testing Device Sales Volume (2021-2032)
  5. 1.2.3 Global Network Point-of-Care Glucose Testing Device Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Network Point-of-Care Glucose Testing Device Market Dynamics
  1. 2.1 Network Point-of-Care Glucose Testing Device Industry Trends
  2. 2.2 Network Point-of-Care Glucose Testing Device Industry Drivers
  3. 2.3 Network Point-of-Care Glucose Testing Device Industry Opportunities and Challenges
  4. 2.4 Network Point-of-Care Glucose Testing Device Industry Restraints
3 Network Point-of-Care Glucose Testing Device Market by Company
  1. 3.1 Global Network Point-of-Care Glucose Testing Device Company Revenue Ranking in 2025
  2. 3.2 Global Network Point-of-Care Glucose Testing Device Revenue by Company (2021-2026)
  3. 3.3 Global Network Point-of-Care Glucose Testing Device Sales Volume by Company (2021-2026)
  4. 3.4 Global Network Point-of-Care Glucose Testing Device Average Price by Company (2021-2026)
  5. 3.5 Global Network Point-of-Care Glucose Testing Device Company Ranking (2024-2026)
  6. 3.6 Global Network Point-of-Care Glucose Testing Device Company Manufacturing Base and Headquarters
  7. 3.7 Global Network Point-of-Care Glucose Testing Device Company Product Type and Application
  8. 3.8 Global Network Point-of-Care Glucose Testing Device Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Network Point-of-Care Glucose Testing Device Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Network Point-of-Care Glucose Testing Device Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Network Point-of-Care Glucose Testing Device Market by Type
  1. 4.1 Network Point-of-Care Glucose Testing Device Type Introduction
  2. 4.1.1 0.5uL/0.6uL
  3. 4.1.2 1.5uL
  4. 4.1.3 1uL
  5. 4.1.4 Others
  6. 4.2 Global Network Point-of-Care Glucose Testing Device Sales Volume by Type
  7. 4.2.1 Global Network Point-of-Care Glucose Testing Device Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Network Point-of-Care Glucose Testing Device Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Network Point-of-Care Glucose Testing Device Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Network Point-of-Care Glucose Testing Device Sales Value by Type
  11. 4.3.1 Global Network Point-of-Care Glucose Testing Device Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Network Point-of-Care Glucose Testing Device Sales Value by Type (2021-2032)
  13. 4.3.3 Global Network Point-of-Care Glucose Testing Device Sales Value Share by Type (2021-2032)
5 Network Point-of-Care Glucose Testing Device Market by Application
  1. 5.1 Network Point-of-Care Glucose Testing Device Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Household
  5. 5.2 Global Network Point-of-Care Glucose Testing Device Sales Volume by Application
  6. 5.2.1 Global Network Point-of-Care Glucose Testing Device Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Network Point-of-Care Glucose Testing Device Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Network Point-of-Care Glucose Testing Device Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Network Point-of-Care Glucose Testing Device Sales Value by Application
  10. 5.3.1 Global Network Point-of-Care Glucose Testing Device Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Network Point-of-Care Glucose Testing Device Sales Value by Application (2021-2032)
  12. 5.3.3 Global Network Point-of-Care Glucose Testing Device Sales Value Share by Application (2021-2032)
6 Network Point-of-Care Glucose Testing Device Regional Sales and Value Analysis
  1. 6.1 Global Network Point-of-Care Glucose Testing Device Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Network Point-of-Care Glucose Testing Device Sales by Region (2021-2032)
  3. 6.2.1 Global Network Point-of-Care Glucose Testing Device Sales by Region: 2021-2026
  4. 6.2.2 Global Network Point-of-Care Glucose Testing Device Sales by Region (2027-2032)
  5. 6.3 Global Network Point-of-Care Glucose Testing Device Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Network Point-of-Care Glucose Testing Device Sales Value by Region (2021-2032)
  7. 6.4.1 Global Network Point-of-Care Glucose Testing Device Sales Value by Region: 2021-2026
  8. 6.4.2 Global Network Point-of-Care Glucose Testing Device Sales Value by Region (2027-2032)
  9. 6.5 Global Network Point-of-Care Glucose Testing Device Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Network Point-of-Care Glucose Testing Device Sales Value (2021-2032)
  12. 6.6.2 North America Network Point-of-Care Glucose Testing Device Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Network Point-of-Care Glucose Testing Device Sales Value (2021-2032)
  15. 6.7.2 Europe Network Point-of-Care Glucose Testing Device Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Network Point-of-Care Glucose Testing Device Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Network Point-of-Care Glucose Testing Device Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Network Point-of-Care Glucose Testing Device Sales Value (2021-2032)
  21. 6.9.2 South America Network Point-of-Care Glucose Testing Device Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Network Point-of-Care Glucose Testing Device Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Network Point-of-Care Glucose Testing Device Sales Value Share by Country, 2025 VS 2032
7 Network Point-of-Care Glucose Testing Device Country-level Sales and Value Analysis
  1. 7.1 Global Network Point-of-Care Glucose Testing Device Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Network Point-of-Care Glucose Testing Device Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Network Point-of-Care Glucose Testing Device Sales by Country (2021-2032)
  4. 7.3.1 Global Network Point-of-Care Glucose Testing Device Sales by Country (2021-2026)
  5. 7.3.2 Global Network Point-of-Care Glucose Testing Device Sales by Country (2027-2032)
  6. 7.4 Global Network Point-of-Care Glucose Testing Device Sales Value by Country (2021-2032)
  7. 7.4.1 Global Network Point-of-Care Glucose Testing Device Sales Value by Country (2021-2026)
  8. 7.4.2 Global Network Point-of-Care Glucose Testing Device Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Network Point-of-Care Glucose Testing Device Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Network Point-of-Care Glucose Testing Device Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Network Point-of-Care Glucose Testing Device Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Network Point-of-Care Glucose Testing Device Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Network Point-of-Care Glucose Testing Device Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Network Point-of-Care Glucose Testing Device Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Network Point-of-Care Glucose Testing Device Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Network Point-of-Care Glucose Testing Device Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Network Point-of-Care Glucose Testing Device Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Network Point-of-Care Glucose Testing Device Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Network Point-of-Care Glucose Testing Device Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Network Point-of-Care Glucose Testing Device Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Network Point-of-Care Glucose Testing Device Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Network Point-of-Care Glucose Testing Device Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Network Point-of-Care Glucose Testing Device Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Network Point-of-Care Glucose Testing Device Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Network Point-of-Care Glucose Testing Device Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Network Point-of-Care Glucose Testing Device Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Network Point-of-Care Glucose Testing Device Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Network Point-of-Care Glucose Testing Device Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Network Point-of-Care Glucose Testing Device Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Network Point-of-Care Glucose Testing Device Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Network Point-of-Care Glucose Testing Device Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Network Point-of-Care Glucose Testing Device Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Network Point-of-Care Glucose Testing Device Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Network Point-of-Care Glucose Testing Device Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Network Point-of-Care Glucose Testing Device Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Network Point-of-Care Glucose Testing Device Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Network Point-of-Care Glucose Testing Device Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Network Point-of-Care Glucose Testing Device Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Network Point-of-Care Glucose Testing Device Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Network Point-of-Care Glucose Testing Device Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Network Point-of-Care Glucose Testing Device Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Network Point-of-Care Glucose Testing Device Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Network Point-of-Care Glucose Testing Device Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Network Point-of-Care Glucose Testing Device Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Network Point-of-Care Glucose Testing Device Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Network Point-of-Care Glucose Testing Device Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Network Point-of-Care Glucose Testing Device Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Network Point-of-Care Glucose Testing Device Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Network Point-of-Care Glucose Testing Device Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Network Point-of-Care Glucose Testing Device Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Network Point-of-Care Glucose Testing Device Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Network Point-of-Care Glucose Testing Device Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Network Point-of-Care Glucose Testing Device Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Network Point-of-Care Glucose Testing Device Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Network Point-of-Care Glucose Testing Device Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Network Point-of-Care Glucose Testing Device Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Network Point-of-Care Glucose Testing Device Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Network Point-of-Care Glucose Testing Device Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Network Point-of-Care Glucose Testing Device Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Network Point-of-Care Glucose Testing Device Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Network Point-of-Care Glucose Testing Device Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Network Point-of-Care Glucose Testing Device Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Network Point-of-Care Glucose Testing Device Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Network Point-of-Care Glucose Testing Device Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Network Point-of-Care Glucose Testing Device Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Network Point-of-Care Glucose Testing Device Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Network Point-of-Care Glucose Testing Device Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Network Point-of-Care Glucose Testing Device Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Network Point-of-Care Glucose Testing Device Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Network Point-of-Care Glucose Testing Device Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Network Point-of-Care Glucose Testing Device Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Network Point-of-Care Glucose Testing Device Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Network Point-of-Care Glucose Testing Device Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Network Point-of-Care Glucose Testing Device Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Network Point-of-Care Glucose Testing Device Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Network Point-of-Care Glucose Testing Device Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Network Point-of-Care Glucose Testing Device Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Network Point-of-Care Glucose Testing Device Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Network Point-of-Care Glucose Testing Device Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Network Point-of-Care Glucose Testing Device Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Network Point-of-Care Glucose Testing Device Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Network Point-of-Care Glucose Testing Device Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Network Point-of-Care Glucose Testing Device Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Network Point-of-Care Glucose Testing Device Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Network Point-of-Care Glucose Testing Device Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Network Point-of-Care Glucose Testing Device Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Network Point-of-Care Glucose Testing Device Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Network Point-of-Care Glucose Testing Device Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Network Point-of-Care Glucose Testing Device Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Network Point-of-Care Glucose Testing Device Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Network Point-of-Care Glucose Testing Device Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Network Point-of-Care Glucose Testing Device Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Johnson & Johnson
  2. 8.1.1 Johnson & Johnson Company Information
  3. 8.1.2 Johnson & Johnson Business Overview
  4. 8.1.3 Johnson & Johnson Network Point-of-Care Glucose Testing Device Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Johnson & Johnson Network Point-of-Care Glucose Testing Device Product Portfolio
  6. 8.1.5 Johnson & Johnson Recent Developments
  7. 8.2 Trividia Health, Inc.
  8. 8.2.1 Trividia Health, Inc. Company Information
  9. 8.2.2 Trividia Health, Inc. Business Overview
  10. 8.2.3 Trividia Health, Inc. Network Point-of-Care Glucose Testing Device Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Trividia Health, Inc. Network Point-of-Care Glucose Testing Device Product Portfolio
  12. 8.2.5 Trividia Health, Inc. Recent Developments
  13. 8.3 Terumo
  14. 8.3.1 Terumo Company Information
  15. 8.3.2 Terumo Business Overview
  16. 8.3.3 Terumo Network Point-of-Care Glucose Testing Device Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Terumo Network Point-of-Care Glucose Testing Device Product Portfolio
  18. 8.3.5 Terumo Recent Developments
  19. 8.4 Roche Holding AG
  20. 8.4.1 Roche Holding AG Company Information
  21. 8.4.2 Roche Holding AG Business Overview
  22. 8.4.3 Roche Holding AG Network Point-of-Care Glucose Testing Device Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Roche Holding AG Network Point-of-Care Glucose Testing Device Product Portfolio
  24. 8.4.5 Roche Holding AG Recent Developments
  25. 8.5 Prodigy Diabetes Care
  26. 8.5.1 Prodigy Diabetes Care Company Information
  27. 8.5.2 Prodigy Diabetes Care Business Overview
  28. 8.5.3 Prodigy Diabetes Care Network Point-of-Care Glucose Testing Device Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Prodigy Diabetes Care Network Point-of-Care Glucose Testing Device Product Portfolio
  30. 8.5.5 Prodigy Diabetes Care Recent Developments
  31. 8.6 Panasonic Healthcare Holdings
  32. 8.6.1 Panasonic Healthcare Holdings Company Information
  33. 8.6.2 Panasonic Healthcare Holdings Business Overview
  34. 8.6.3 Panasonic Healthcare Holdings Network Point-of-Care Glucose Testing Device Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Panasonic Healthcare Holdings Network Point-of-Care Glucose Testing Device Product Portfolio
  36. 8.6.5 Panasonic Healthcare Holdings Recent Developments
  37. 8.7 Omron
  38. 8.7.1 Omron Company Information
  39. 8.7.2 Omron Business Overview
  40. 8.7.3 Omron Network Point-of-Care Glucose Testing Device Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Omron Network Point-of-Care Glucose Testing Device Product Portfolio
  42. 8.7.5 Omron Recent Developments
  43. 8.8 Nova Biomedical
  44. 8.8.1 Nova Biomedical Company Information
  45. 8.8.2 Nova Biomedical Business Overview
  46. 8.8.3 Nova Biomedical Network Point-of-Care Glucose Testing Device Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Nova Biomedical Network Point-of-Care Glucose Testing Device Product Portfolio
  48. 8.8.5 Nova Biomedical Recent Developments
  49. 8.9 Nipro
  50. 8.9.1 Nipro Company Information
  51. 8.9.2 Nipro Business Overview
  52. 8.9.3 Nipro Network Point-of-Care Glucose Testing Device Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Nipro Network Point-of-Care Glucose Testing Device Product Portfolio
  54. 8.9.5 Nipro Recent Developments
  55. 8.10 LifeScan, Inc.
  56. 8.10.1 LifeScan, Inc. Company Information
  57. 8.10.2 LifeScan, Inc. Business Overview
  58. 8.10.3 LifeScan, Inc. Network Point-of-Care Glucose Testing Device Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 LifeScan, Inc. Network Point-of-Care Glucose Testing Device Product Portfolio
  60. 8.10.5 LifeScan, Inc. Recent Developments
  61. 8.11 EKF Diagnostics
  62. 8.11.1 EKF Diagnostics Company Information
  63. 8.11.2 EKF Diagnostics Business Overview
  64. 8.11.3 EKF Diagnostics Network Point-of-Care Glucose Testing Device Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 EKF Diagnostics Network Point-of-Care Glucose Testing Device Product Portfolio
  66. 8.11.5 EKF Diagnostics Recent Developments
  67. 8.12 Danaher Corporation
  68. 8.12.1 Danaher Corporation Company Information
  69. 8.12.2 Danaher Corporation Business Overview
  70. 8.12.3 Danaher Corporation Network Point-of-Care Glucose Testing Device Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Danaher Corporation Network Point-of-Care Glucose Testing Device Product Portfolio
  72. 8.12.5 Danaher Corporation Recent Developments
  73. 8.13 B. Braun
  74. 8.13.1 B. Braun Company Information
  75. 8.13.2 B. Braun Business Overview
  76. 8.13.3 B. Braun Network Point-of-Care Glucose Testing Device Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 B. Braun Network Point-of-Care Glucose Testing Device Product Portfolio
  78. 8.13.5 B. Braun Recent Developments
  79. 8.14 Ascensia Diabetes Care Holdings AG
  80. 8.14.1 Ascensia Diabetes Care Holdings AG Company Information
  81. 8.14.2 Ascensia Diabetes Care Holdings AG Business Overview
  82. 8.14.3 Ascensia Diabetes Care Holdings AG Network Point-of-Care Glucose Testing Device Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Ascensia Diabetes Care Holdings AG Network Point-of-Care Glucose Testing Device Product Portfolio
  84. 8.14.5 Ascensia Diabetes Care Holdings AG Recent Developments
  85. 8.15 AgaMatrix
  86. 8.15.1 AgaMatrix Company Information
  87. 8.15.2 AgaMatrix Business Overview
  88. 8.15.3 AgaMatrix Network Point-of-Care Glucose Testing Device Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 AgaMatrix Network Point-of-Care Glucose Testing Device Product Portfolio
  90. 8.15.5 AgaMatrix Recent Developments
  91. 8.16 ACON Laboratories, Inc.
  92. 8.16.1 ACON Laboratories, Inc. Company Information
  93. 8.16.2 ACON Laboratories, Inc. Business Overview
  94. 8.16.3 ACON Laboratories, Inc. Network Point-of-Care Glucose Testing Device Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 ACON Laboratories, Inc. Network Point-of-Care Glucose Testing Device Product Portfolio
  96. 8.16.5 ACON Laboratories, Inc. Recent Developments
  97. 8.17 77 Elektronika
  98. 8.17.1 77 Elektronika Company Information
  99. 8.17.2 77 Elektronika Business Overview
  100. 8.17.3 77 Elektronika Network Point-of-Care Glucose Testing Device Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 77 Elektronika Network Point-of-Care Glucose Testing Device Product Portfolio
  102. 8.17.5 77 Elektronika Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Network Point-of-Care Glucose Testing Device Value Chain Analysis
  2. 9.1.1 Network Point-of-Care Glucose Testing Device Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Network Point-of-Care Glucose Testing Device Sales Mode & Process
  6. 9.2 Network Point-of-Care Glucose Testing Device Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Network Point-of-Care Glucose Testing Device Distributors
  9. 9.2.3 Network Point-of-Care Glucose Testing Device Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst